249 related articles for article (PubMed ID: 29749571)
1. Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.
Enooku K; Kondo M; Fujiwara N; Sasako T; Shibahara J; Kado A; Okushin K; Fujinaga H; Tsutsumi T; Nakagomi R; Minami T; Sato M; Nakagawa H; Kondo Y; Asaoka Y; Tateishi R; Ueki K; Ikeda H; Yoshida H; Moriya K; Yotsuyanagi H; Kadowaki T; Fukayama M; Koike K
J Gastroenterol; 2018 Dec; 53(12):1261-1275. PubMed ID: 29749571
[TBL] [Abstract][Full Text] [Related]
2. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients.
Enooku K; Tsutsumi T; Kondo M; Fujiwara N; Sasako T; Shibahara J; Kado A; Okushin K; Fujinaga H; Nakagomi R; Minami T; Sato M; Uchino K; Nakagawa H; Kondo Y; Asaoka Y; Tateishi R; Ueki K; Ikeda H; Yoshida H; Moriya K; Yotsuyanagi H; Kadowaki T; Koike K
J Gastroenterol; 2020 Feb; 55(2):227-243. PubMed ID: 31602526
[TBL] [Abstract][Full Text] [Related]
3. The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.
Morio R; Hyogo H; Hatooka M; Morio K; Kan H; Kobayashi T; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Masayasu Y; Chayama K
J Gastroenterol; 2017 Feb; 52(2):253-262. PubMed ID: 27351871
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
Coccia F; Testa M; Guarisco G; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):106-113. PubMed ID: 31677889
[TBL] [Abstract][Full Text] [Related]
5. Association of IRS1 (Gly972Arg) and IRS2 (Gly1057Asp) genes polymorphisms with OSA and NAFLD in Asian Indians.
Bhatt SP; Guleria R
PLoS One; 2021; 16(8):e0245408. PubMed ID: 34449768
[TBL] [Abstract][Full Text] [Related]
6. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
8. Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers.
Honma M; Sawada S; Ueno Y; Murakami K; Yamada T; Gao J; Kodama S; Izumi T; Takahashi K; Tsukita S; Uno K; Imai J; Kakazu E; Kondo Y; Mizuno K; Kawagishi N; Shimosegawa T; Katagiri H
Int J Obes (Lond); 2018 Sep; 42(9):1544-1555. PubMed ID: 29717275
[TBL] [Abstract][Full Text] [Related]
9. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
[TBL] [Abstract][Full Text] [Related]
10. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation.
Abdelmoemen G; Khodeir SA; Zaki AN; Kassab M; Abou-Saif S; Abd-Elsalam S
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):185-188. PubMed ID: 30009716
[TBL] [Abstract][Full Text] [Related]
12. Multi-layered epigenetic regulation of IRS2 expression in the liver of obese individuals with type 2 diabetes.
Krause C; Geißler C; Tackenberg H; El Gammal AT; Wolter S; Spranger J; Mann O; Lehnert H; Kirchner H
Diabetologia; 2020 Oct; 63(10):2182-2193. PubMed ID: 32710190
[TBL] [Abstract][Full Text] [Related]
13. Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone.
Chai SY; Pan XY; Song KX; Huang YY; Li F; Cheng XY; Qu S
Lipids Health Dis; 2014 Jan; 13():7. PubMed ID: 24397589
[TBL] [Abstract][Full Text] [Related]
14. The role of incretin hormones and glucagon in patients with liver disease.
Junker AE
Dan Med J; 2017 May; 64(5):. PubMed ID: 28552096
[TBL] [Abstract][Full Text] [Related]
15. A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease.
Dabiri R; Mahmoudi T; Sabzikarian M; Asadi A; Farahani H; Nobakht H; Maleki I; Mansour-Ghanaei F; Derakshshan F; Zali MR
Acta Gastroenterol Belg; 2020; 83(2):271-276. PubMed ID: 32603046
[TBL] [Abstract][Full Text] [Related]
16. Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease.
Bechmann LP; Gastaldelli A; Vetter D; Patman GL; Pascoe L; Hannivoort RA; Lee UE; Fiel I; Muñoz U; Ciociaro D; Lee YM; Buzzigoli E; Miele L; Hui KY; Bugianesi E; Burt AD; Day CP; Mari A; Agius L; Walker M; Friedman SL; Reeves HL
Hepatology; 2012 Apr; 55(4):1083-93. PubMed ID: 22095588
[TBL] [Abstract][Full Text] [Related]
17. Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis.
Bril F; Lomonaco R; Orsak B; Ortiz-Lopez C; Webb A; Tio F; Hecht J; Cusi K
Hepatology; 2014 Jun; 59(6):2178-87. PubMed ID: 24777953
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?
Gastaldelli A
Clin Sci (Lond); 2017 Nov; 131(22):2701-2704. PubMed ID: 29109303
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
